Autologous tolerogenic dendritic cells (ATDC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous tolerogenic dendritic cells (ATDC), covering 2025-02-28 to 2025-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients [Phase 1]